Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II.

Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II.

Item
http://www.wikidata.org/entity/Q45912062
New perspectives of valproic acid in clinical practice.The Histone Deacetylase Inhibitor Vaproic Acid Induces Cell Growth Arrest in Hepatocellular Carcinoma Cells via Suppressing Notch Signaling.Transcriptional regulation of E-cadherin and oncoprotein E7 by valproic acid in HPV positive cell lines.Notch Signaling Activation in Cervical Cancer Cells Induces Cell Growth Arrest with the Involvement of the Nuclear Receptor NR4A2.Emerging biological treatments for uterine cervical carcinoma.Anti-Epileptic Drug Targets Ewing Sarcoma.Activated Notch signaling augments cell growth in hepatocellular carcinoma via up-regulating the nuclear receptor NR4A2.Valproic acid, an inhibitor of class I histone deacetylases, reverses acquired Erlotinib-resistance of lung adenocarcinoma cells: a Connectivity Mapping analysis and an experimental study.Differences in specificity and selectivity between CBP and p300 acetylation of histone H3 and H3/H4.HDAC inhibitors suppressed small cell lung cancer cell growth and enhanced the suppressive effects of receptor-targeting cytotoxins via upregulating somatostatin receptor II.Synergistic effect of cytokine-induced killer cell with valproate inhibits growth of hepatocellular carcinoma cell in a mouse model.Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4.
P2860

Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II.

Item
http://www.wikidata.org/entity/Q45912062
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Valproic acid suppresses cervi ...... somatostatin receptor type II.
@en
Valproic acid suppresses cervi ...... somatostatin receptor type II.
@nl
type
label
Valproic acid suppresses cervi ...... somatostatin receptor type II.
@en
Valproic acid suppresses cervi ...... somatostatin receptor type II.
@nl
prefLabel
Valproic acid suppresses cervi ...... somatostatin receptor type II.
@en
Valproic acid suppresses cervi ...... somatostatin receptor type II.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P921
P356
P1433
P1476
Valproic acid suppresses cervi ...... somatostatin receptor type II.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P921